AirLife® continues to shape the future of neonatal care with a comprehensive resuscitation portfolio designed to safeguard fragile lungs from the very first breath through NICU discharge.
“The most important and effective step in neonatal resuscitation is to ventilate the newborn infant’s lungs.”
— Neonatal Resuscitation Program (NRP), 9th Edition
On October 22, 2025, the American Academy of Pediatrics (AAP) and the American Heart Association (AHA) unveiled the 9th Edition of the Neonatal Resuscitation Program (NRP) alongside the updated 2025 Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. These landmark updates reaffirm that effective ventilation is not simply a step—it is the foundation of successful newborn resuscitation.
Precision Tools for Critical Moments
AirLife® products are engineered to support clinicians in delivering guideline-driven care with confidence:
- SafeT™ T-Piece Infant Resuscitator
- Provides controlled, reliable ventilation with precision.
- Clinical guidance: Using a T-piece resuscitator for positive-pressure ventilation is preferred over a self-inflating bag.
- Air-Q®3 NEO Supraglottic Airway
- Enables rapid placement to establish effective ventilation without delay.
- Clinical guidance: For infants ≥ 34 0/7 weeks’ gestation, a supraglottic airway may be considered as the primary interface for positive-pressure ventilation instead of a face mask.
Commitment to Best Practice
By aligning with the latest NRP recommendations, AirLife® empowers neonatal teams to deliver care that is both evidence-based and outcome-focused. Every product in the portfolio is designed to transform ventilation from a variable maneuver into a controlled, measurable intervention—helping clinicians achieve consistency, safety, and improved patient outcomes.